Gonadotrophin-releasing hormone analogues: A novel treatment for premenstrual asthma

European Respiratory Journal

Volumn 14, Issue 4, 1999, Pages 966-967

  Murray, R D ^a   New, J P ^a   Barber, P V ^b   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Gonadotrophin releasing hormone agonists; Premenstrual asthma

Indexed keywords

GONADORELIN; GONADORELIN DERIVATIVE; PREDNISOLONE;

ADJUVANT THERAPY; ADULT; ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLOW UP; GONADOTROPIN RELEASE; HUMAN; MENSTRUAL CYCLE; OVARY FUNCTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GOSERELIN; HUMANS; PEAK EXPIRATORY FLOW RATE; PREMENSTRUAL SYNDROME;

EID: 0032727883     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14d39.x     Document Type: Article

References (6)

1. Gibbs CJ, Lock R, Finnegan OC, White RJ. Premenstrual exacerbation of asthma. Thorax 1984; 39: 833-836.
2. Chandler MH, Schuldheisz S, Phillips BA, Muse KN. Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 1997; 17: 224-234.
3. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996; 156: 1837-1840.
4. Beynon HL, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988; 2: 370-372.
5. Boggess KA, Williamson HO, Homm RJ. Influence of the menstrual cycle on systemic diseases. Obstet Gynecol Clin North Am 1990; 17: 321-342.
6. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382-387.